{"id":"W3027401261","doi":"10.1007/s10461-020-02929-8","title":"Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks","year":2020,"lang":"en","type":"article","venue":"AIDS and Behavior","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; GlaxoSmithKline (Canada)","funders":"Janssen Pharmaceuticals; Sanofi Pasteur; ViiV Healthcare; GlaxoSmithKline","keywords":"Rilpivirine; Medicine; Tolerability; Internal medicine; Adverse effect; Human immunodeficiency virus (HIV); Surgery; Antiretroviral therapy; Viral load; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001092332,0.0001180994,0.0003268068,0.00009197256,0.00004351107,0.00001705961,0.00002309893,0.00005418093,0.0001135734],"category_scores_gemma":[0.0002253235,0.00008892949,0.00005364906,0.0001240224,0.0001019315,0.00008065326,0.00006293847,0.0001889726,0.000003062885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001224602,"about_ca_system_score_gemma":0.00002088779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004601015,"about_ca_topic_score_gemma":0.0001510022,"domain_scores_codex":[0.9989768,0.00003817108,0.0003279747,0.0002340702,0.0001898196,0.0002331177],"domain_scores_gemma":[0.9994494,0.00004830752,0.00007815027,0.0001250934,0.00004000133,0.0002590281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001361616,0.0003475926,0.9363742,0.00007469924,0.00003961904,0.0001782015,0.0005414663,8.00092e-8,0.01099,0.00001947468,0.0003315636,0.05096689],"study_design_scores_gemma":[0.00202813,0.004578094,0.9886213,0.0002057195,0.0001679058,0.00001641501,0.0004451293,0.00008681531,0.003483972,0.000006489375,0.0002643819,0.000095681],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986699,0.000160925,0.000005848123,0.0005182727,0.00001721332,0.0003200274,0.00002288063,0.00001379389,0.000271171],"genre_scores_gemma":[0.99852,0.00007309607,0.000101685,0.000095432,0.00001625823,0.00002835613,0.00001183347,0.00001228924,0.001141076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05224702,"threshold_uncertainty_score":0.3626439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05573644676772745,"score_gpt":0.3634146622868343,"score_spread":0.3076782155191068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}